Corporate News Update – 22 October 2026
Lode Resources Ltd (LDR.AX)
- Price movement (last 24 h): Up 2.53 % to AUD 0.08.
- Current trading price: AUD 0.08 on major exchanges.
- Shares outstanding: 197.9 million.
- Market capitalization: AUD 16 million.
- Volume traded (last 24 h): Approximately AUD 810.
- Performance since previous month‑end: Down 22.86 %.
- 200‑day simple moving average: AUD 0.13.
- 52‑week high: AUD 0.26 (15 January 2026).
- 52‑week low: AUD 0.08 (16 July 2026).
Company profile Lode Resources Ltd is a mining company focused on exploring and developing gold, silver, and copper deposits in the New England Fold Belt.
Related Stock Performance (last 24 h)
| Stock | Symbol | Price change | Current price | Market cap | Notable corporate action |
|---|---|---|---|---|---|
| Enero | EGG.AX | +2.38 % | AUD 0.22 | AUD 19.1 million | – |
| Inoviq | IIQ.AX | –3.70 % | AUD 0.13 | AUD 19 million | 2026 Annual General Meeting announced (23 November). Agenda includes financial statement review, remuneration report, re‑election of Director Helen Fisher, and shareholder‑approved incentive schemes for MD/CEO Phil Hodgson. |
| Genmin | GEN.AX | –9.09 % | AUD 0.01 | AUD 19 million | – |
| Acumentis | ACU.AX | +2.33 % | AUD 0.09 | AUD 19.2 million | Filed change of director’s interest notice. Mr. Timothy Rabbitt acquired additional ordinary shares through on‑market purchase from Dragonfly Investments (QLD) Pty Ltd. Filing complies with ASX Listing Rule 3.19A.2. |
| Proteomics Lab | PIQ.AX | 0 % | AUD 0.12 | AUD 19 million | Received a USD 2.0 million R&D tax incentive for FY 2025‑26. Annual General Meeting scheduled for 20 November 2026, covering financial statements, director re‑elections, and CEO incentive securities. |
Summary
Lode Resources Ltd experienced a modest gain of 2.53 % in the most recent 24‑hour trading period, bringing its share price to AUD 0.08. Despite this short‑term increase, the stock remains down 22.86 % from the previous month‑end. The company’s market cap of AUD 16 million is supported by a trading volume of roughly AUD 810 in the last 24 hours. Related peers in the sector showed mixed performance, with Inoviq announcing its upcoming AGM and shareholder resolutions, Acumentis filing a director interest change, and Proteomics Lab reporting a significant R&D tax incentive.
